InMode

OverviewSuggest Edit

InMode (formerly known as Invasix) is a medical device company that manufactures and markets radio-frequency aesthetic platforms. InMode provides body contouring, skin resurfacing, skin rejuvenation, hair removal, and other cosmetic procedures. InMode has non-invasive options for fractional skin resurfacing and contraction, hair removal, skin pigmentation, and vascular lesions.
TypePublic
Founded2008
HQLake Forest, CA, USMap
Websiteinmodemd.com
Employee Ratings2.8More

Recent NewsAll News

Latest Updates

Employees (est.) (Jun 2019)209
Revenue (FY, 2019)$156.4 M(+57%)
Share Price (Jan 2021)$50.2 (+2%)
Cybersecurity ratingDMore

Key People/Management at InMode

Moshe Mizrahy

Moshe Mizrahy

Chief Executive Officer and Chairman of Board
Shakil Lakhani

Shakil Lakhani

President, North America
Yair Malca

Yair Malca

Chief Financial Officer
Uri Michaelis

Uri Michaelis

Vice President, Asia and Pacific Region
Wanda Cummings

Wanda Cummings

VP East Clinical Operations
Michael Kreindel

Michael Kreindel

Chief Technology Officer and Director
Show more

InMode Office Locations

InMode has offices in Lake Forest and Richmond Hill
Lake Forest, CA, US (HQ)
20996 Bake Pkwy #106
Richmond Hill, CA
100 Leek Crescent Unit 15
Show all (2)

InMode Financials and Metrics

InMode Revenue

Embed Graph
View revenue for all periods
InMode's revenue was reported to be $156.36 m in FY, 2019
USD

Revenue (FY, 2019)

156.4m

Gross profit (FY, 2019)

136.1m

Gross profit margin (FY, 2019), %

87.1%

Net income (FY, 2019)

61.1m

EBIT (FY, 2019)

59.6m

Market capitalization (8-Jan-2021)

1.6b

Closing stock price (8-Jan-2021)

50.2

Cash (31-Dec-2019)

44.7m

EV

1.6b
InMode's current market capitalization is $1.6 b.
USDFY, 2017FY, 2018FY, 2019

Revenue

53.5m100.2m156.4m

Revenue growth, %

87%

Cost of goods sold

9.1m15.1m20.2m

Gross profit

44.4m85.1m136.1m
show all
USDFY, 2017FY, 2018FY, 2019

Cash

17.6m24.7m44.7m

Accounts Receivable

5.8m7.0m6.6m

Inventories

5.0m7.0m9.4m

Current Assets

37.1m77.8m213.2m
show all
USDFY, 2017FY, 2018FY, 2019

Net Income

8.8m22.4m61.2m

Depreciation and Amortization

204.0k184.0k302.0k

Inventories

(2.3m)(1.9m)(2.4m)

Accounts Payable

92.0k
show all
USDFY, 2017

Financial Leverage

2 x
Show all financial metrics

InMode Acquisitions / Subsidiaries

Company NameDateDeal Size
Guangzhou InMode Medical Technology Ltd.
InMode Asia Limited.
InMode India Private Limited
InMode Japan KK
InMode M.D. Ltd.
Invasix Corp.
Invasix Iberia S.L.
Invasix Inc.
Invasix UK Ltd.

InMode Revenue Breakdown

Embed Graph

InMode revenue breakdown by geographic segment: 5.7% from Europe, 89.2% from North America and 5.1% from Other

InMode Cybersecurity Score

Cybersecurity ratingPremium dataset

D

66/100

Learn more about our premium products
SecurityScorecard logo

InMode Online and Social Media Presence

InMode's Trends

Embed Graph

InMode News and Updates

October 20, 2020

InMode Introduces Morpheus8 Body Multi-pulse Burst Technology

LAKE FOREST, Calif., Oct. 20, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to introduce to the market the Morpheus8 Body Multi-pulse Burst Radiofrequency Vulcanization Technology. Expanding on the...
October 13, 2020

Thinking about trading options or stock in Inmode, Johnson & Johnson, Bank of America, Ford, or Micron Technology?

NEW YORK, Oct. 13, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for INMD, JNJ, BAC, F, and MU. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different options...
March 02, 2020

InMode to Present at Barclays Global Healthcare Conference

YOKNEAM, Israel, March 2, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, announced today that Moshe Mizrahy, Chairman and Chief Executive Officer, will present at the Barclays Global Healthcare Conference at the...
January 27, 2020

InMode Launches Evoke, the First and Only Hands-free Facial Remodeling Technology

LAKE FOREST, California, Jan. 27, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, introduces Evoke, a breakthrough non-invasive solution for facial remodeling. Evoke is the first hands-free device for the face and...

 InMode Frequently Asked Questions

  • When was InMode founded?

    InMode was founded in 2008.

  • Who are InMode key executives?

    InMode's key executives are Moshe Mizrahy, Shakil Lakhani and Yair Malca.

  • How many employees does InMode have?

    InMode has 209 employees.

  • What is InMode revenue?

    Latest InMode annual revenue is $156.4 m.

  • What is InMode revenue per employee?

    Latest InMode revenue per employee is $748.1 k.

  • Who are InMode competitors?

    Competitors of InMode include Argen, Meta Biomed and EDI.

  • Where is InMode headquarters?

    InMode headquarters is located at 20996 Bake Pkwy #106, Lake Forest.

  • Where are InMode offices?

    InMode has offices in Lake Forest and Richmond Hill.

  • How many offices does InMode have?

    InMode has 2 offices.